A review of the research literature reports that electroencephalogram (EEG) biofeedback, also known as neurofeedback, is a promising intervention for patients with attention deficit/hyperactivity disorder, comparable in efficacy to stimulant medications.

Researchers from Washington State Toxicology Laboratory reviewed the literature on Electroencephalogram (EEG) biofeedback, also known as neurofeedback, to assess its promise as an alternative treatment for patients with attention deficit/hyperactivity disorder (AD/HD). (EEG biofeedback therapy rewards scalp EEG frequencies that are associated with relaxed attention, and suppresses frequencies associated with under- or over-arousal.)

This review reports that in large-scale clinical trials, the efficacy of EEG biofeedback for AD/HD is comparable to that of stimulant medications. Many different EEG biofeedback protocols for AD/HD are available. In particular, single-channel protocols developed by Lubar and inter-hemispheric protocols developed by the Othmers are widely practiced and supported by large-scale clinical studies.

Citation: Friel PN. EEG biofeedback in the treatment of attention deficit hyperactivity disorder. Alternative Medicine Review. 2007 Jun; 12 (2): pages 146-51. This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

---

Add this page to your favorite Social Bookmarking websites

Comments (0)

Subscribe to this comment's feed

Show/hide comments

Show/hide comment form